Javad Aman has been the President and Chief Scientific Officer (CSO) of Integrated BioTherapeutics, Inc. (IBT), a US biotechnology company focused on the discovery of vaccines and immunotherapeutics for emerging infectious diseases. Since 2007, he has led a group of 40 people working on several programmes on the discovery and development of vaccines and antibody therapeutics for several multidrug-resistant bacteria, primarily S. aureus as well as several viral diseases.